Cargando…

Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients

BACKGROUND: Serum alanine aminotransferase (ALT) levels are often considered a marker to evaluate liver disease and its severity. AIM: To investigate the association between ALT levels and all-cause and cause-specific mortality in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Jia-Rui, Wang, Zi-Long, Jiang, Su-Zhen, Chen, Hong-Song, Feng, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308293/ https://www.ncbi.nlm.nih.gov/pubmed/37397938 http://dx.doi.org/10.4254/wjh.v15.i6.813

Ejemplares similares

The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2016)

Independent Association of Physical Activity with Nonalcoholic Fatty Liver Disease and Alanine Aminotransferase Levels
por: Jang, Dong Kee, et al.
Publicado: (2019)

Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients
por: Yu, Hong-Sheng, et al.
Publicado: (2023)

Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease
por: Kwon, Kyoung Ah, et al.
Publicado: (2016)

Effect of illness uncertainty on alanine transaminase levels and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease
por: Ozawa, Naoki, et al.
Publicado: (2022)

The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis
por: Rangboo, Vajiheh, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
por: Miyake, Teruki, et al.
Publicado: (2021)

Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients
por: Cheng, Jin-Lin, et al.
Publicado: (2017)

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
por: Kim, Donghee, et al.
Publicado: (2023)

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease
por: Castillo-Leon, Eduardo, et al.
Publicado: (2022)

The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015)

Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease
por: Oh, Hyo Jeong, et al.
Publicado: (2011)

Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial
por: Atefi, Masoumeh, et al.
Publicado: (2022)

Higher Serum 25-Hydroxyvitamin D Is Associated with Lower All-Cause and Cardiovascular Mortality among US Adults with Nonalcoholic Fatty Liver Disease
por: Chen, Yuxiong, et al.
Publicado: (2022)

The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet
por: Shidfar, Farzad, et al.
Publicado: (2018)

Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data
por: Arsik, Idil, et al.
Publicado: (2018)

Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome
por: Sogabe, Masahiro, et al.
Publicado: (2020)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
por: Pitisuttithum, Panyavee, et al.
Publicado: (2020)

Significantly Reduced Alanine Aminotransferase Level Increases All-Cause Mortality Rate in the Elderly after Ischemic Stroke
por: An, Sang Joon, et al.
Publicado: (2021)

Cytokeratin 18, Alanine Aminotransferase, Platelets and Triglycerides Predict the Presence of Nonalcoholic Steatohepatitis
por: Cao, Wei, et al.
Publicado: (2013)

Association between alanine aminotransferase within the normal range and all-cause and cause-specific mortality: A nationwide cohort study
por: Visaria, Aayush, et al.
Publicado: (2020)

Validation of Dynamic Aspartate‐to–Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality
por: Song, In‐Ae, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults
por: Umehara, Toshihiro
Publicado: (2018)

Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy
por: Martin-Rodriguez, Jose Luis, et al.
Publicado: (2017)

THU139 The Triglyceride-glucose Index Combined With Alanine Aminotransferase Is A Superior Predictor Of The Severity Of Nonalcoholic Fatty Liver Disease In Children And Adolescents
por: Yoon, Jong Seo, et al.
Publicado: (2023)

Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver
por: Omagari, Katsuhisa, et al.
Publicado: (2011)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Interrelationship between physical activity and depression in nonalcoholic fatty liver disease
por: Weinstein, Ali A, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2019)

Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults
por: Sun, Xingxing, et al.
Publicado: (2021)

High Aspartate Aminotransferase/Alanine Aminotransferase Ratio May Be Associated with All-Cause Mortality in the Elderly: A Retrospective Cohort Study Using Artificial Intelligence and Conventional Analysis
por: Nakajima, Kei, et al.
Publicado: (2022)

Serum HBV RNA as a predictor of virological response in treatment-naive chronic HBeAg-positive HBV-infected patients with normal alanine aminotransferase
por: Qian, Jiandan, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings
por: Khosravi, Somaye, et al.
Publicado: (2011)

Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population
por: Klisic, Aleksandra, et al.
Publicado: (2019)

Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure
por: Maeda, Daichi, et al.
Publicado: (2021)

Association between alanine aminotransferase and all‐cause mortality rate: Findings from a study on Japanese community‐dwelling individuals
por: Kawamoto, Ryuichi, et al.
Publicado: (2022)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

Association between aminotransferase/alanine aminotransferase ratio and cardiovascular disease mortality in patients on peritoneal dialysis: a multi-center retrospective study
por: Feng, Xiaoran, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n2hoi1338nqqe8n9pqpc8f5qb1